Vikas Lifecare Faces ₹22.99 Crore Income Tax Demand, Plans Appeal

Vikas Lifecare Limited has disclosed receiving an Income Tax demand order totaling ₹22.99 crore. The company is currently reviewing the order and has stated its intention to file an appeal against the tax assessment.

Details of the Tax Demand

The demand, dated March 27, 2026, covers several assessment years and stems from additions and disallowances made by tax authorities.

Company's Appeal Plans and Immediate Outlook

Vikas Lifecare stated it is assessing the financial implications of the order. Management indicated that the demand is not expected to have an immediate material impact on the company's day-to-day operations while the appeal process is underway.

Financial Implications and Shareholder Risk

Such tax demands can represent a significant financial liability, potentially affecting cash flow and profitability if upheld. Shareholders are now exposed to this contingent liability of ₹22.99 crore pending the appeal's outcome. The primary risk lies in the demand itself and the uncertainty of the appeal process, which could result in the demand being upheld fully or partially.

Background on Vikas Lifecare

Vikas Lifecare Limited, previously known as Vikas Multicorp Ltd, operates across diverse sectors including healthcare, agrochemicals, and polymer compounds. In a separate matter, promoters associated with its former name faced SEBI debarment in 2022 due to takeover violations, which was unrelated to Vikas Lifecare's tax matters.

Industry Context and Peer Challenges

Operating in regulated sectors like chemicals and healthcare, companies such as Vikas Lifecare, and its peers like Aanjaneya Active Ingredients Ltd, Valiant Organics Ltd, and Kshitij Polyline Ltd, often encounter tax scrutiny. Managing tax demands is a common challenge within these industries.

What Investors Will Track Next

Investors will monitor the company's progress in filing the appeal and await any updates from tax appellate authorities. Management's commentary on financial preparedness for potential adverse outcomes will also be closely watched.